ScholarIQanswers from OpenAlex & ORCID
Chris J. Packard
ResearcherPublications, citations & collaboration network
Chris J. Packard is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Chris J. Packard have?
ScholarIQindexed works
Chris J. Packard has 310 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Chris J. Packard have?
ScholarIQcitation count
Chris J. Packard has 42,438 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Chris J. Packard?
ScholarIQh-index
Chris J. Packard has an h-index of 89 in OpenAlex.
What is the i10-index of Chris J. Packard?
ScholarIQi10-index
Chris J. Packard has an i10-index of 212 in OpenAlex.
What is the ORCID of Chris J. Packard?
ScholarIQorcid
The ORCID for Chris J. Packard is on the source record.
What is the OpenAlex record for Chris J. Packard?
ScholarIQopenalex
The OpenAlex for Chris J. Packard is on the source record.
What are the most-cited papers on Chris J. Packard?
ScholarIQmost cited works
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
Brian A. Ference, Henry N. Ginsberg, Ian Graham, Kausik K. Ray, Chris J. Packard, Éric Bruckert, Robert A. Hegele, Ronald M. Krauss, Frederick J. Raal, Heribert Schunkert, Gerald F. Watts, Jan Borén, Sergio Fazio, Jay D. Horton, L. Masana, Stephen J. Nicholls, Børge G. Nordestgaard, Bart van de Sluis, Marja‐Riitta Taskinen, Lâle Tokgözoğlu, Ulf Landmesser, Ulrich Laufs, Olov Wiklund, Jane K. Stock, M. John Chapman, Alberico L. Catapano
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
James Shepherd, Gerard J. Blauw, Michael Murphy, Edward Bollen, Brendan M. Buckley, Stuart M. Cobbe, Ian Ford, Allan Gaw, Michael E. Hyland, J. Wouter Jukema, Adriaan M. Kamper, Peter W. Macfarlane, A. Edo Meinders, John Norrie, Chris J. Packard, Ivan J. Perry, David J. Stott, Brian Sweeney, Gillian Twomey, Rudi GJ Westendorp
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
Naveed Sattar, David Preiss, Heather Murray, Paul Welsh, Brendan M. Buckley, Anton JM de Craen, Sreenivasa Rao Kondapally Seshasai, John J.V. McMurray, Dilys J. Freeman, J. Wouter Jukema, Peter W. Macfarlane, Chris J. Packard, David J. Stott, Rudi G. J. Westendorp, James Shepherd, Barry R. Davis, Sara Pressel, Roberto Marchioli, Rosa Maria Marfisi, Aldo P. Maggioni, Luigi Tavazzi, Gianni Tognoni, John Kjekshus, Terje R. Pedersen, Thomas J. Cook, Antonio M. Gotto, Michael Clearfield, John R. Downs, Haruo Nakamura, Yasuo Ohashi, Kyoichi Mizuno, Kausik K. Ray, Ian Ford
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
Jan Borén, M. John Chapman, Ronald M. Krauss, Chris J. Packard, Jacob Fog Bentzon, Christoph J. Binder, Mat J.A.P. Daemen, Linda L. Demer, Robert A. Hegele, Stephen J. Nicholls, Børge G. Nordestgaard, Gerald F. Watts, Éric Bruckert, Sergio Fazio, Brian A. Ference, Ian Graham, Jay D. Horton, Ulf Landmesser, Ulrich Laufs, L. Masana, Gerard Pasterkamp, Frederick J. Raal, Kausik K. Ray, Heribert Schunkert, Marja‐Riitta Taskinen, Bart van de Sluis, Olov Wiklund, Lâle Tokgözoğlu, Alberico L. Catapano, Henry N. Ginsberg
Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study
Naveed Sattar, Allan Gaw, Olga Scherbakova, Ian Ford, D S O’Reilly, Steven M. Haffner, Chris Isles, Peter W. Macfarlane, Chris J. Packard, Stuart M. Cobbe, James Shepherd